Welcome to the Pharmacy Homepage
The Colorado State Board of Pharmacy regulates pharmacists, pharmacy interns, pharmacy technicians, in-state and nonresident pharmacies, in-state and out-of-state prescription drug wholesalers, satellite pharmacies, specialized prescription drug outlets, other outlets, and limited licenses. The Board upholds consumer protection by licensing qualified applicants, investigating complaints, and enforcing disciplinary actions against violators of the Pharmacists, Pharmacy Business and Pharmaceuticals Act and the Board's rules.
The Board consists of five pharmacist members and two public members and works in conjunction with the Federal Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), Colorado Pharmacists Society, RxPlus Pharmacies, and the Colorado Retail Council.
Program Information
- Program/Board Members
-
Dmitry Kunin, Senior Program Director
State Board of Pharmacy
1560 Broadway, Suite 1350
Denver, CO 80202Phone: 303-894-7800 | Fax: 303-894-7692 | Email: dora_pharmacyboard@state.co.us
Board Members:
-
James Hansen, RPh, MBA, President
Term Expires: July 1, 2023 -
Avani Soni, Pharm.D., RPh, Vice President
Term Expires: July 1, 2025 -
Kristen Wolf, PharmD, BCSCP
Term Expires: July 1, 2023 -
Patricia A.Evacko, PharmD.
Term Expires: July 1, 2026 -
Eric Frazer, Pharm.D.
Term Expires: July 1, 2025 -
Casey Frank, JD, MPH
Term Expires: July 1, 2023 -
Brian C. Gonzales, MSW, LCSW, LAC
Term Expires: July 1, 2023
-
- Public Notices
-
Emergency and Permanent Rulemaking Hearing - September 29, 2022
The State Board of Pharmacy will hold an Emergency and Permanent Rulemaking Hearing to allow stakeholders a final opportunity to provide testimony before the Board considers adopting multiple proposed new and revised rules to implement stakeholder recommendations, new legislation, and executive orders. The Board will consider all proposed rules on a permanent basis, and in addition, will consider emergency adoption of new Rules 32.00.00 and 33.00.00 to fulfill the 90-day reporting requirements of the Executive Orders. The proposed rules based on stakeholder recommendations include the following topics: third-party logistics providers, reporting requirements, collaborative practice agreements, Appendix A, Appendix C, and Appendix E. The new and revised rules proposed for legislative and executive implementation regard: Colorado Senate Bills 21-094, 22-116, and 22-173; Colorado House Bills 22-1284, 22-1235, 22-1246, and 22-1326; and Executive Orders D 2022-032 and D 2022-034.
- Thursday, September 29, 2022, at 9:00 A.M. (MDT)
- Notice, Draft Rules, Written Comments, SB21-094, SB22-116, SB22-173, HB22-1284, HB22-1235, HB22-1246, HB22-1326, EO D 2022-032, and EO D 2022-034
- (HB22-1284) Joint Stakeholder Meeting: August 12, 2022
- Stakeholder Meeting: August 5, 2022
- (EO D 2022-034) Joint Stakeholder Meeting: July 29, 2022
- Stakeholder Meeting: June 27, 2022
- (EO D 2022-032) Joint Stakeholder Meeting: July 22, 2022
- (SB22-116) Joint Stakeholder Meeting: June 10, 2022
- (HIV Protocol) Stakeholder Meeting: April 25, 2022
- (Contraceptive Protocol) Joint Stakeholder Meeting: February 14, 2022
- (Statin Therapy) Joint Stakeholder Meeting: December 20, 2021
Joint Stakeholder Meeting - August 29, 2022
The Division of Profession and Occupations held a Joint Stakeholder Meeting for all Healthcare Boards with Prescriptive Authority to allow stakeholders an opportunity to provide feedback on the implementation of Colorado House Bill 22-1115 (Concerning the Prescription Drug Monitoring Program, and, in connection therewith, making an appropriation).
Joint Stakeholder Meeting - October 15, 2021
The State Board of Pharmacy, State Board of Nursing, Colorado Medical Board, Colorado Dental Board, Colorado Podiatry Board, State Board of Veterinary Medicine, and State Board of Optometry held a Joint Stakeholder Meeting to gather feedback to identify and create a list of prescription drugs and substances (using evidence-based practices), in addition to controlled substances, that have a substantial potential for abuse and must require pharmacists and prescription drug outlets to report those prescription drugs and substances to the Prescription Drug Monitoring Program (PDMP) when dispensed to a patient. The Board is considering the development of new rules to monitor non-controlled prescription drugs/substances, as allowed per section 12-280-404(2)(b)(I), C.R.S., of Colorado Senate Bill 21-098.
- Notice and SB21-098
- Joint Stakeholder Meeting (recording): October 15, 2021
Rulemaking Hearing - September 30, 2021he State Board of Pharmacy held a Permanent Rulemaking Hearing on September 30, 2021, that allowed stakeholders a final opportunity to provide feedback before the Board considered adopting new and revised rules that were recommended by the Board and stakeholders to provide clarity and a general cleanup of the rules; and the implementation of Colorado Senate Bill 21-011 (Concerning responsibilities of a pharmacist related to opiate antagonists); Colorado Senate Bill 21-077 (Concerning the elimination of verification of an individual's lawful presence in the United States as a requirement for individual credentialing); Colorado Senate Bill 21-094 (Concerning the continuation of the State Board of Pharmacy, and, in connection therewith, implementing recommendations contained in the 2020 sunset report by the Department of Regulatory Agencies and making other changes regarding the practice of professions regulated by the board); Colorado Senate Bill 21-098 (Concerning the continuation of the prescription drug monitoring program); Colorado Senate Bill 21-122 (Concerning the bulk purchase of opiate antagonists pursuant to a standing order); and Colorado Senate Bill 21-123 (Concerning expanding the Canadian prescription drug importation program to include prescription drug suppliers from nations other than Canada upon the enactment of legislation by the United States congress authorizing such practice).
- Legislative Updates
-
- 2022 New Legislation
- HB22-1041: Privacy Protections For Protected Persons
- HB22-1098: Department Of Regulatory Agencies Barriers To Practice Regulated Professions
- HB22-1115: Prescription Drug Monitoring Program
- HB22-1165: Rule Review Bill
- HB22-1240: Mandatory Reporters
- HB22-1246: Hospice Inpatient Unit Specialized Prescription Drug Outlet
- HB22-1257: 2022 Criminal And Juvenile Justice Commission Recommendations
- HB22-1267 Culturally Relevant Training Health Professionals
- HB22-1270: Change Term Name-based Criminal History Record Check
- HB22-1278: Behavioral Health Administration
- HB22-1309: Hospital Dispense Drugs To Sexual Assault Victims
- HB22-1326: Fentanyl Accountability And Prevention
- HB22-1291: Sunrise Review Professions Occupations
- SB22-013: Boards and Commissions
- SB22-027: Prescription Drug Monitoring Program
- SB22-076: Complaint Occupational License Official Acts
- SB22-098 Program Allowing Redispensing Of Unused Drugs
- SB22-116 Increase Occupational Credential Portability
- SB22-140 Expansion Of Experiential Learning Opportunities
- SB22-143 Update Common Provision Term Regulator Title 12
- SB22-162: Administration Organization Act Modernization
- SB22-173: Telepharmacy Criteria Remove Location Restriction
- SB22-174: Sunset Review Hearing Criteria
- SB22-226: Programs To Support Health-care Workforce
- 2021 New Legislation
- HB21-1012 Expand Prescription Drug Monitoring Program
- HB21-1198: Healthcare Billing Requirements for Indigent Patients
- HB 21-1123: CAPS Check for Substantiated Cases of Mistreatment of an At-Risk Adult
- HB21-1169: Prohibit Discrimination Organ Transplant Recipient
- HB21-1232: Standardized Health Benefit Plan Colorado Option
- HB21-1276 Prevention of Substance Use Disorders
- HB21-1297: Pharmacy Benefit Manager and Insurer Requirements
- HB21-1300: Health-care Provider Liens for Injured Persons
- HB21-1307: Prescription Insulin Pricing And Access
- SB21-011: Pharmacist Prescribe Dispense Opiate Antagonist
- SB21-077: Remove Lawful Presence Verification Credentialing
- SB21-094: Sunset Continue State Board of Pharmacy
- SB21-097: Sunset Medical Transparency Act
- SB21-098: Sunset Prescription Drug Monitoring Program
- SB21-122: Opiate Antagonist Bulk Purchase And Standing Orders
- SB21-123: Expand Canadian Rx Import Program
- SB21-271: Misdemeanor Reform
- 2022 New Legislation
- Meeting Minutes
-
Board Meeting Minutes
- January 19, 2023, Pharmacy Board Meeting Minutes
- November 17, 2022, Pharmacy Board Meeting Minutes
- September 29, 2022, Pharmacy Board Meeting Minutes
Veterinary Pharmaceutical Advisory Committee (VPAC) Minutes